lonidamine has been researched along with Carcinoma, Epidermoid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biglietto, M; Carteni, G; De Cesare, M; Pacilio, G | 1 |
| Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Mermillod, B | 1 |
| Angelini, F; Ausili Cefaro, GP; Blengio, F; Cirulli, S; Cognetti, F; Colella, E; Giannarelli, D; Lo Russo, V; Merlano, M; Scasso, F | 1 |
| Bardelli, D; Bertoni, F; Ciottoli, GB; Magno, L; Rosignoli, MT; Terraneo, F; Tordiglione, M | 1 |
| Berni, F; Calzavara, MP; Cattaneo, MT; D'Adda, D; Filipazzi, V; Frontini, L; Isa, L; Legnani, W; Rho, B; Scapaticci, R | 1 |
| Canova, N; Casadio, M; Guaraldi, M; Lelli, G; Pannuti, F | 1 |
| Danjoux, CE; DeSanctis, AJ; Feeley, MM; Fisher, B; Maroun, J; Martin, L; Raaphorst, GP | 1 |
| Ciottoli, GB; De Gregorio, M; Kokron, O; Maca, S | 1 |
| Ciottoli, GB; De Gregorio, M; De Luca, B; Greco, S; Magnani, F; Marletta, F; Palmucci, T; Patanè, C; Privitera, G; Tafuri, G | 1 |
1 review(s) available for lonidamine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
5 trial(s) available for lonidamine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Indazoles; Male; Middle Aged; Muscles; Pyrazoles; Random Allocation | 1984 |
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Indazoles; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1994 |
Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Indazoles; Lymphatic Metastasis; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis; Time Factors | 1994 |
Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Double-Blind Method; Drug Evaluation; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Pyrazoles | 1987 |
4 other study(ies) available for lonidamine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged | 1993 |
A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Remission Induction | 1990 |
The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell lines.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Survival; Cricetinae; Fibroblasts; Glioma; Humans; Hyperthermia, Induced; Indazoles; Melanoma; Mice; Neoplasms; Radiotherapy; Tumor Cells, Cultured | 1991 |
Phase II study of lonidamine in non-small cell lung cancer: final report.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pyrazoles | 1990 |